Aug 172020
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, MA – Stoke Therapeutics, Inc., (Nasdaq: STOK), a biotechnology company pioneering a new way to treat the underlying cause of genetic diseases by precisely upregulating protein expression, today announced the appointment of Dr. Garry Menzel, Ph.D., to its Board of Directors. He will also be appointed to the ...

Stoke Therapeutics appoints Dr Garry Menzel to its Board of Directors

Stoke Therapeutics appoints Dr Garry Menzel to its Board of Directors

From:: Stoke Therapeutics appoints Dr Garry Menzel to its Board of Directors

Sorry, the comment form is closed at this time.